Related Experiment Video

Updated: Oct 10, 2026

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
08:05

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

Published on: May 19, 2021

[Density of beta-adrenergic receptors and left ventricular mass in patients with primary essential hypertension]

J Gajek1, D Zyśko, A Spring

  • 1Katedry i Kliniki Kardiologii AM we Wrocławiu.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|November 18, 2000
PubMed

Insights

Beta-adrenergic receptor density remained unchanged in hypertensive patients and did not correlate with left ventricular mass. However, elevated blood pressure showed a strong correlation with left ventricular mass in stage II hypertension.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Molecular Cardiology

Background:

  • Left ventricular hypertrophy (LVH) is a significant risk factor for sudden cardiac death.
  • Hypertension is a primary driver of LVH, with the sympathetic nervous system potentially playing a key role.
  • Understanding the relationship between neurohumoral mechanisms and cardiac remodeling is crucial in managing hypertension.

Purpose of the Study:

  • To investigate the density of beta-adrenergic receptors in hypertensive patients.
  • To examine the relationship between beta-adrenergic receptor density and left ventricular mass index (LVMI).
  • To explore the correlation between blood pressure levels and LVMI in hypertensive individuals.

Main Methods:

  • Recruited 63 patients with primary hypertension (Stage I and II) and 26 healthy controls.
  • Assessed beta-adrenergic receptor density using the 125I-cyanopindolol radioligand labeling method.
  • Measured left ventricular dimensions via echocardiography to calculate LVMI; analyzed correlations between variables.

Main Results:

  • Hypertensive patients exhibited significantly higher systolic and diastolic blood pressure and LVMI compared to controls.
  • No significant difference was found in beta-adrenergic receptor density between hypertensive patients and controls.
  • Beta-adrenergic receptor density did not correlate with LVMI in the hypertensive group.
  • A significant positive correlation was observed between LVMI and both systolic and diastolic blood pressure, particularly in Stage II hypertension.

Conclusions:

  • Beta-adrenergic receptor density is not altered in hypertension and does not correlate with LVMI.
  • A strong positive correlation exists between blood pressure and LVMI, specifically in patients with Stage II hypertension.
Abstract

More Related Videos

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Related Concept Videos

Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...